se of the GnRh Agonist to Improve Outcome IVF

Not Applicable

• Conditions: Condition 1: Infertility. Condition 2: Endometriosis preparation for freezing embryo transfer.; Female infertility; complication associated with artificial fertilization ,unspecified; N98.9

• Registration Number: IRCT20190916044781N1
• Lead Sponsor: Sarem Fertility and Infertility Research Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 240

Inclusion Criteria

Have at least two embryos for transfer.
The embryo has been removed from the freeze after thawing and has grade A quality.
Absence of internal uterine anomalies such as adenomyosis and uterine fibroids and uterine malformations
Absence of clear endometrioma
Patients who used the agonist protocol in the ICSI cycle.
Absence of systemic diseases (such as collagen, vascular disease, chronic hypertension, diabetes: a well-known case of diabetes with a fasting FBS of over 126)
Vitamin D should be modified before starting ICSI.
Age range from 25 to 40 years.

Exclusion Criteria

Determine endometrioma during FET.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy. Timepoint: Day 14 after transfer. Method of measurement: laboratory tests.